Baader Bank Aktiengesellschaft Boosts Position in Doximity, Inc. (NASDAQ:DOCS)

Baader Bank Aktiengesellschaft grew its holdings in Doximity, Inc. (NASDAQ:DOCS) by 85.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,100 shares of the company’s stock after acquiring an additional 5,100 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Doximity were worth $593,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. UMB Bank n.a. boosted its holdings in Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the period. Quarry LP boosted its stake in shares of Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after buying an additional 131,253 shares during the last quarter. Morse Asset Management Inc acquired a new stake in Doximity during the third quarter worth about $46,000. Finally, GAMMA Investing LLC raised its position in Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after acquiring an additional 412 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Trading Up 2.3 %

DOCS stock opened at $59.00 on Friday. The company has a market capitalization of $11.02 billion, a PE ratio of 67.82, a P/E/G ratio of 4.43 and a beta of 1.38. The business’s fifty day moving average price is $54.35 and its 200 day moving average price is $44.26. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $61.75.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.02). Doximity had a net margin of 33.69% and a return on equity of 19.79%. The business had revenue of $136.83 million during the quarter, compared to analysts’ expectations of $127.05 million. During the same period in the previous year, the business posted $0.18 EPS. Research analysts predict that Doximity, Inc. will post 0.88 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on DOCS shares. KeyCorp dropped their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $60.00 price objective (up previously from $40.00) on shares of Doximity in a report on Wednesday, November 13th. Bank of America increased their target price on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Raymond James restated an “outperform” rating and issued a $65.00 price target (up previously from $37.00) on shares of Doximity in a research note on Friday, November 8th. Finally, The Goldman Sachs Group initiated coverage on Doximity in a research note on Friday, November 15th. They issued a “neutral” rating and a $58.00 target price for the company. Thirteen investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $53.12.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.